Report copyright - MAY 2017 PAGE 1 TOO HS May 2017d.pdf · MAY 2017 PAGE 1 Dr. McLaughlin and col-leagues developed vessel-sparing RT with the intention of delivering the prescribed RT dose to the prostate
Please pass captcha verification before submit form